Document is current
Any future updates will be listed below
-
Authors
Usai, Carla https://orcid.org/0000-0002-6373-2765
Ainsua-Enrich, Erola
Gales, Victor Urrea https://orcid.org/0000-0002-2577-856X
Pradenas, Edwards https://orcid.org/0000-0001-5162-8920
Lorca-Oró, Cristina
Tarrés-Freixas, Ferran
Roca, Núria
Pérez, Mónica
Ávila-Nieto, Carlos
Rodríguez de la Concepción, María Luisa
Pedreño-Lopez, Núria https://orcid.org/0000-0001-6927-2301
Carabelli, Julieta https://orcid.org/0000-0003-2329-3996
Trinité, Benjamin https://orcid.org/0000-0003-3809-042X
Ballana, Ester
Riveira-Muñoz, Eva
Izquierdo-Useros, Nuria https://orcid.org/0000-0002-1039-1821
Clotet, Bonaventura
Blanco, Julià https://orcid.org/0000-0002-2225-0217
Guallar, Victor
Cantero, Guillermo
Vergara-Alert, Júlia
Carrillo, Jorge https://orcid.org/0000-0003-0221-5948
Segalés, Joaquim https://orcid.org/0000-0002-1539-7261
- License Information
-
More Information
Article History
Received: 14 August 2023
Accepted: 9 February 2024
First Online: 27 February 2024
Competing interests
: No potential conflict of interest was reported by the authors. Unrelated to the submitted work, JB and JC are founders and shareholders of AlbaJuna Therapeutics, S.L. BC is founder and shareholder of AlbaJuna Therapeutics, S.L. and AELIX Therapeutics, S.L, and V.G is founder and shareholder of Nostrum Biodiscovery.
